![Bernd Eisele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernd Eisele
Amministratore Delegato presso Vakzine Projekt Management GmbH
Posizioni attive di Bernd Eisele
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vakzine Projekt Management GmbH
![]() Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Amministratore Delegato | 16/11/2009 | - |
Direttore Tecnico/Scientifico/R&S | 16/11/2009 | - |
Storia della carriera di Bernd Eisele
Precedenti posizioni note di Bernd Eisele
Società | Posizione | Inizio | Fine |
---|---|---|---|
Behringwerke AG
![]() Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Corporate Officer/Principal | 01/01/1996 | 01/01/1996 |
Abbott Products GmbH | Corporate Officer/Principal | 01/01/1996 | - |
Formazione di Bernd Eisele
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Vakzine Projekt Management GmbH
![]() Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
Behringwerke AG
![]() Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Health Technology |
Abbott Products GmbH |
- Borsa valori
- Insiders
- Bernd Eisele
- Esperienza